Compositional assessment of low-grade cartilage lesions using T2 mapping at 3 
and 7 Tesla MRI: a one year follow-up study

Juras, V; Schreiner, M; Laurent, D; Zbyn, S; Mlynarik, V; Szomolanyi, P; Scotti, C; Goldhahn, J; Haber, H; Kubiak, E; Marlovits, S; Heule, R; Bieri, O; Frollo, I; Trattnig, S

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Meeting Abstract

Compositional assessment of low-grade cartilage lesions using T2 mapping at 3 and 7 Tesla MRI: a one year follow-up study

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

https://archive.ismrm.org/2018/5038.html
(Abstract)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Juras, V., Schreiner, M., Laurent, D., Zbyn, S., Mlynarik, V., Szomolanyi, P., et al. (2018). Compositional assessment of low-grade cartilage lesions using T2 mapping at 3 and 7 Tesla MRI: a one year follow-up study. In Joint Annual Meeting ISMRM-ESMRMB 2018.

Cite as: https://hdl.handle.net/21.11116/0000-000B-0434-6

Abstract

T2 maps were assessed as a potential marker for the long-term follow-up of the patients with cartilage lesions ICRS Grade I-II in five time points (baseline, 8 days, 3, 6 and 12 months). For the T2 mapping, a 3D triple echo steady state sequence which is capable of delivering high quality high-resolved T2 maps at ultra-high field MRI was used. We observed a significant decrease in T2 values at 3T over time in superficial zone of the cartilage defect. There was no statistically significant change at 7T. T2 mapping could be used in the future as a good alternative to cartilage biopsies in clinical trials on new therapies aimed at cartilage regeneration.